Tenet Healthcare Corporation
THC Healthcare Medical Care Facilities
In the quarter to June 2026, revenue grew 14.6%, EPS grew 213.0%, free cash flow fell 43.9% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years.
Follow THC
Tenet Healthcare Corporation (THC) Piotroski F-score
Tenet Healthcare Corporation's Piotroski F-score for fiscal 2025 is 7 out of 9: 7 of nine tests of profitability, leverage and efficiency passed, unchanged from fiscal 2024.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 7 | 0.00 |
| FY2024 | 7 | (2.00) |
| FY2023 | 9 | 5.00 |
| FY2022 | 4 | (3.00) |
| FY2021 | 7 | 1.00 |
| FY2020 | 6 | 1.00 |
| FY2019 | 5 | (1.00) |
| FY2018 | 6 | 3.00 |
| FY2017 | 3 | (2.00) |
| FY2016 | 5 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | 4.80% | 11.18% | Pass | 1 |
| Positive operating cash flow | 3.54b | 2.05b | Pass | 1 |
| Rising return on assets | 4.80% | 11.18% | Fail | 0 |
| Cash flow above net income | 2.13b | (1.15b) | Pass | 1 |
| Falling long-term leverage | 0.45 | 0.46 | Pass | 1 |
| Rising current ratio | 1.76 | 1.78 | Fail | 0 |
| No new shares issued | 90,150,000 | 96,904,000 | Pass | 1 |
| Rising gross margin | 41.41% | 39.79% | Pass | 1 |
| Rising asset turnover | 0.73 | 0.72 | Pass | 1 |
| Piotroski F-score | Strong — most fundamentals improved | 7 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 8 |
| UHS Universal Health Services, Inc. compare | 8 |
| ENSG The Ensign Group, Inc. compare | 7 |
| EHC Encompass Health Corporation compare | 7 |
| THC Tenet Healthcare Corporation | 7 |
| PACS PACS Group, Inc. compare | 7 |
| CHE Chemed Corporation compare | 6 |
| DVA DaVita Inc. compare | 6 |
| CON Concentra Group Holdings Parent, Inc. compare | 6 |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover